#Breast_cancer is the most frequently occurring
#cancer in women and the second most common cancer
globally. Globally, more than two million new cases of breast cancer were
reported in 2018. It’s estimated that about 7% of all breast cancer cases
diagnosed occur in women under the age of 40. According to the American Cancer
Society, about one in eight invasive breast cancers develop in women younger
than 45, whereas two in three invasive breast cancers occur in #women aged 55
or older. Breast cancer occurrence also differs between patients diagnosed
before and after menopause. Although breast
cancer may occur in men, its occurrence is rare, and one in a thousand men
may be diagnosed with breast cancer in their lifetime.
Breast cancer is regarded as a #heterogeneous
disease — the way it develops and affects individual patients varies greatly.
Some breast cancer subtypes are #hormone-dependent. Breast cancer cells that
possess #oestrogen receptors are defined as oestrogen-positive (ER+). #Breast_cancer
cells containing progesterone receptors are called progesterone-positive (PR+)
cancers. Hormone receptor-positive cancers occur more frequently. Hormone
receptor-positive cancers also have improved prognosis. Hormone receptor-negative
cancers may be more difficult to treat, and have the likelihood of a higher
pathological grade.
Preventative surgery may decrease the risk of
breast cancer, but does not provide a 100% certainty that the person will not
develop cancer. Frequent surveillance and screenings should be considered. #Medication
as preventative therapy may also be considered to assist high-risk women to
decrease their risk of being diagnosed with cancer. The elimination of #cancer
requires a combination of cancer awareness to address the burden of this
disease — prevention strategies, contributing to early detection and promoting
health and well-being education and the acceleration of science and discovery
and progress in technology.
For more details please follow the link: https://frontiersmeetings.com/conferences/breastcancercongress/
For queries and details contact us: breastcancer@globalbreastcancercongress.org
#Breast_Cancer_congress_2020 #Zurich #Switzerland #June15-17_2020 #Breast
#cancer #Awareness #october #Breast_cancer #Immunotherapy #chemotherapy #Tumor
#Breast_Surgery #mastectomy #carcinoma #Breast_conference #Keynote
#Oral_sessions